Russell Investments Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Buy |
11,190
+10,950
| +4,563% | +$154K | ﹤0.01% | 2708 |
|
|
2025
Q1 | $3.75K | Hold |
240
| – | – | ﹤0.01% | 3408 |
|
|
2024
Q4 | $3.34K | Sell |
240
-9,144
| -97% | -$127K | ﹤0.01% | 3358 |
|
|
2024
Q3 | $87.3K | Buy |
9,384
+8,381
| +836% | +$77.9K | ﹤0.01% | 2686 |
|
|
2024
Q2 | $9.33K | Buy |
1,003
+982
| +4,676% | +$9.13K | ﹤0.01% | 3091 |
|
|
2024
Q1 | $208 | Buy |
+21
| New | +$208 | ﹤0.01% | 3276 |
|
|
2023
Q1 | – | Sell |
-15,972
| Closed | -$236K | – | 3293 |
|
|
2022
Q4 | $236K | Buy |
15,972
+2,774
| +21% | +$41.1K | ﹤0.01% | 2529 |
|
|
2022
Q3 | $251K | Buy |
+13,198
| New | +$251K | ﹤0.01% | 2487 |
|
|
2021
Q1 | – | Sell |
-1,200
| Closed | -$33K | – | 3097 |
|
|
2020
Q4 | $33K | Sell |
1,200
-400
| -25% | -$11K | ﹤0.01% | 2951 |
|
|
2020
Q3 | $46K | Buy |
+1,600
| New | +$46K | ﹤0.01% | 3081 |
|